Molecular Mechanisms in Rheumatic Diseases: Rationale for Novel Drug Development - Introduction

By  

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 10, Iss. 2, 2011-04 ,pp. : 73-77

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot-Topic: Molecular Mechanisms in Rheumatic Diseases:Rationale for Novel Drug Development (Guest Editor: Charles J. Malemud)]

By  

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 10, Iss. 2, 2011-04 ,pp. : 72-72

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot-Topic: Molecular Mechanisms in Rheumatic Diseases:Rationale for Novel Drug Development (Guest Editor: Charles J. Malemud)]

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 10, Iss. 2, 2011-04 ,pp. : 72-72

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Synthetic Lethality Approaches for Drug Combinations and Early Drug Development

By  

Current Cancer Drug Targets, Vol. 17, Iss. 1, 2016-12 ,pp. : 48-52

Bentham Science Publishers

Access to resources Recommend Favorite

Serotonin-2 Receptor Agonists as Novel Ocular Hypotensive Agents and their Cellular and Molecular Mechanisms of Action: Novel Drug Targets for Glaucoma Treatment

By  

Current Drug Targets, Vol. 11, Iss. 8, 2010-01 ,pp. : 978-993

Bentham Science Publishers

Access to resources Recommend Favorite